immuneAdvice, is a pre-seed, preclinical radiodiagnostics start-up based in Reutlingen, Germany, specializing in immune cell tracers (ICE-Ts) for Positron Emission Tomography (PET) imaging. Our lead candidate, CD4 ICE-T, enables the early detection of resistance to immune checkpoint inhibitors (ICIs), allowing for a timely personalized transition to alternative therapies. immuneAdvice is committed to securing approval and reimbursement for CD4 ICE-T in the US and EU, targeting patients with advanced solid tumors.

True to our name, immuneAdvice delivers precise advice on applying immunotherapeutic agents.